• Press Releases
  • News
  • Careers
  • Contact
  • Home
  • About
  • Leadership
  • Pipeline
  • Technology
  • Investors
  • Patients
  • News
  • Careers
  • Contact

Recent Posts

  • Pharmaceutical Manufacturer Q&A: Artiva Allogeneic NK Cell Therapies for Treating Autoimmune Disease
  • GEN: The Body’s Delta Force: Natural Killer Cells Re-Emerge
  • The Bio Report Podcast: Turning Natural Killers into Off-the-Shelf Therapies for Autoimmune Disease
  • In Vivo: Artiva Leverages Unmodified NK Cells To Challenge CAR-T Paradigm
  • Drug Discovery World: Expanding Access to Cell Therapies for Autoimmune Conditions

Archives

  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • November 2024
  • August 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • December 2023
  • November 2023

Categories

  • Artiva In the News

Archives

  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • November 2024
  • August 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • December 2023
  • November 2023

Category: Directors

Brian Daniels, M.D.

Fred Aslan, M.D.

Dan Baker, M.D.

Laura Bessen, M.D.

Elizabeth Hougen

Yong-Jun Huh

Diego Miralles, M.D.

Alison Moore

Laura Stoppel, Ph.D.

  • Contact
  • Privacy Policy
  • Terms

© Artiva Biotherapeutics, Inc., 2025

Sign up for news updates
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.AcceptPrivacy Policy